NO995718L - Urte-ekstraktsammensetning og metode med innum-"boosting"- evne - Google Patents
Urte-ekstraktsammensetning og metode med innum-"boosting"- evneInfo
- Publication number
- NO995718L NO995718L NO995718A NO995718A NO995718L NO 995718 L NO995718 L NO 995718L NO 995718 A NO995718 A NO 995718A NO 995718 A NO995718 A NO 995718A NO 995718 L NO995718 L NO 995718L
- Authority
- NO
- Norway
- Prior art keywords
- extract
- herbal extract
- innum
- boosting
- extract composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Urteekstraktsammensetning som omfatter ekstrakt av ARUM, ekstrakt av GRANATEPLE, ekstrakt av HIB1SCUS og ekstrakt av TE. Urteekstraktsammensetningen ifølge oppfinnelsen viser in vitro stimulering av lymfocyttransformasjon og cytokinfremstilling, og in vitro inhibering av gp!20 binding, og tilveiebringer et potensielt stoff for terapier og behandlinger for immunforstyrrelser og HIV-infeksjon.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/102,355 US6030622A (en) | 1998-06-23 | 1998-06-23 | Herbal extract composition and method with immune-boosting capability |
PCT/US1999/013949 WO1999066941A1 (en) | 1998-06-23 | 1999-06-19 | Herbal extract composition and method with immune-boosting capability |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995718D0 NO995718D0 (no) | 1999-11-22 |
NO995718L true NO995718L (no) | 2000-01-18 |
Family
ID=22289416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995718A NO995718L (no) | 1998-06-23 | 1999-11-22 | Urte-ekstraktsammensetning og metode med innum-"boosting"- evne |
Country Status (23)
Country | Link |
---|---|
US (1) | US6030622A (no) |
EP (1) | EP1032409A4 (no) |
JP (1) | JP2002518454A (no) |
KR (1) | KR20010020586A (no) |
CN (1) | CN1272792A (no) |
AP (1) | AP2000001727A0 (no) |
AU (1) | AU773546B2 (no) |
BG (1) | BG63865B1 (no) |
BR (1) | BR9906480A (no) |
CA (1) | CA2294075A1 (no) |
EA (1) | EA003750B1 (no) |
EE (1) | EE200000053A (no) |
HR (1) | HRP990407A2 (no) |
ID (1) | ID25661A (no) |
IL (1) | IL133441A0 (no) |
NO (1) | NO995718L (no) |
NZ (1) | NZ501405A (no) |
OA (1) | OA11396A (no) |
PL (1) | PL338263A1 (no) |
SK (1) | SK169199A3 (no) |
TR (1) | TR200000501T1 (no) |
WO (1) | WO1999066941A1 (no) |
ZA (1) | ZA997713B (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8603546B2 (en) * | 1999-01-11 | 2013-12-10 | Herbaceuticals Inc. | Herbal supplement for increased muscle strength and endurance for athletes |
WO2000056177A2 (en) * | 1999-03-22 | 2000-09-28 | Stewart And Lynda Resnick Revocable Trust | Pomegranate extracts and methods of using thereof |
US6387418B1 (en) | 1999-04-19 | 2002-05-14 | Stewart And Lynda Resnick Revocable Trust | Pomegranate extracts and methods of using thereof |
US7727563B2 (en) * | 1999-04-19 | 2010-06-01 | Pom Wonderful, Llc | Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans |
US8372454B2 (en) | 1999-04-19 | 2013-02-12 | Pom Wonderful Llc | Methods of making pomegranate compounds for the treatment of erectile dysfunction |
US6641850B1 (en) | 1999-04-19 | 2003-11-04 | Stewart And Lynda Resnick Revocable Trust | Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans |
US6630163B1 (en) * | 1999-04-22 | 2003-10-07 | Howard Murad | Method of treating dermatological disorders with fruit extracts |
US6800292B1 (en) * | 1999-04-22 | 2004-10-05 | Howard Murad | Pomegranate fruit extract compositions for treating dermatological disorders |
US20020197341A1 (en) * | 1999-11-29 | 2002-12-26 | Rimonest Ltd. | Physiologically synergistic mixtures of pomegranate extracts and methods of use thereof |
WO2002008258A2 (en) * | 2000-07-21 | 2002-01-31 | Millennium Pharmaceuticals, Inc. | 65494, a human g-protein-coupled receptor family member and uses thereof |
US20030017219A1 (en) * | 2001-05-25 | 2003-01-23 | Frank Corsini | Carbohydrate modifying agent and drinks containing the modifying agent |
US20030004211A1 (en) * | 2001-05-25 | 2003-01-02 | Frank Corsini | Carbohydrate modifying agent and drinks containing the modifying agent |
EP1463944A4 (en) * | 2001-12-21 | 2006-05-10 | Eastern Virginia Med School | METHOD OF ANALYZING THE EFFECTS OF MEDICINAL AGENTS |
KR20020041348A (ko) * | 2002-02-28 | 2002-06-01 | 이성희 | 면역기능을 강화시킨 바이오 홀몬파워 제조 |
US20040013749A1 (en) * | 2002-07-22 | 2004-01-22 | Young D. Gary | Antioxidant and immune boosting composition and methods of using |
WO2005072722A2 (en) * | 2004-01-20 | 2005-08-11 | Nutrition Therapeutics, Inc. | Method of using punicic acid to enhance immune response and prevent metabolic disorders |
WO2005070412A2 (en) * | 2004-01-20 | 2005-08-04 | Nutrition Therapeutics, Inc. | Method of using punicic acid to enhance immune response and prevent metabolic disorders |
US7507424B2 (en) * | 2004-04-26 | 2009-03-24 | Mmi Corporation | Natural immunostimulant compositions, methods for obtaining the same and pharmaceutical formulations thereof |
US20060062866A1 (en) * | 2004-09-21 | 2006-03-23 | New York Blood Center, Inc. | Starch-pomegranate juice complex as an HIV entry inhibitor and topical microbicide |
US20060189543A1 (en) * | 2005-02-23 | 2006-08-24 | Rosenbloom Richard A | Compositions and methods for the treatment of leukemia |
US9028882B2 (en) | 2005-05-02 | 2015-05-12 | 4Life Patents, Llc | Nutraceutical gels |
MY162337A (en) * | 2005-05-02 | 2017-06-15 | 4Life Res Llc | Transfer factor preparations and associated methods |
US7303772B2 (en) * | 2005-11-10 | 2007-12-04 | Olalde Rangel Jose Angel | Synergistic phytoceutical compositions |
WO2008024543A2 (en) * | 2006-06-01 | 2008-02-28 | Pom Wonderful, Llc | Method of using composition comprising pomegranate extracts against influenza |
US20080031979A1 (en) * | 2006-08-04 | 2008-02-07 | Claude Saliou | Use of extracts for the treatment of viral disorders |
US7811554B2 (en) | 2007-01-19 | 2010-10-12 | Flavio Lozano | Horse liniment |
US20090169654A1 (en) * | 2007-12-14 | 2009-07-02 | Conopco, Inc. D/B/A Unilever | Tea composition and process for the manufacture thereof |
US20090175964A1 (en) * | 2007-12-14 | 2009-07-09 | Conopco, Inc. D/B/A Unilever | Composition for enhancing immunity |
US8257769B2 (en) * | 2007-12-14 | 2012-09-04 | Conopco, Inc. | Process for recovering volatile tea compounds |
US8263140B1 (en) | 2008-04-16 | 2012-09-11 | Pom Wonderful, Llc | Pomegranate based skin protectant and topical application |
US8758835B2 (en) * | 2008-07-31 | 2014-06-24 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composition useful for the prevention or reduction of the progression of prostate cancer |
RU2414210C1 (ru) * | 2009-12-28 | 2011-03-20 | Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика") | Средство для удаления табачных смол и композиции на его основе |
US8039025B1 (en) * | 2010-10-15 | 2011-10-18 | Life Plus, LLC | Methods and dosage forms for the treatment of human cancers |
US20150140125A1 (en) * | 2013-11-19 | 2015-05-21 | Life Plus, LLC | Synergistic cancer therapy drug combinations |
IT202100010409A1 (it) * | 2021-04-23 | 2022-10-23 | Esserre Pharma Srl | Composizione comprendente un fitocomplesso da melograno e suoi usi |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4104373A (en) * | 1969-06-20 | 1978-08-01 | Richard Sichert | Therapeutical composition |
JPS56147719A (en) * | 1980-04-18 | 1981-11-16 | Meiji Seika Kaisha Ltd | Production of dried ginseng |
US4671959A (en) * | 1984-11-14 | 1987-06-09 | Yale University | Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions |
US4886665A (en) * | 1987-03-11 | 1989-12-12 | Arcopharma Ltd. | Compositions of oats and nettle extracts to be used as a food additive or pharmaceutical preparation in human health care |
JPH02286620A (ja) * | 1989-04-27 | 1990-11-26 | Riide Chem Kk | 抗高脂血症用剤 |
WO1991013627A1 (en) * | 1990-03-14 | 1991-09-19 | The Board Of Regents, The University Of Texas System | Tripterygium wilfordii hook f extracts and components thereof for immunosuppression |
US5178865A (en) * | 1990-06-19 | 1993-01-12 | Cedars-Sinai Medical Center | Chinese herbal extracts in the treatment of hiv related disease in vitro |
US5407675A (en) * | 1990-08-10 | 1995-04-18 | Etemad-Moghadam; Parviz | Method and composition for use on the scalp and eyebrow region of a subject |
US5064675A (en) * | 1991-03-01 | 1991-11-12 | Scandinavian Natural Resources Development Hb | Herbal extract composition |
JPH0840B2 (ja) * | 1991-10-31 | 1996-01-10 | 株式会社東洋発酵 | 活性酸素抑制組成物及びその製造方法並びに血圧抑制剤 |
RU2032418C1 (ru) * | 1993-05-19 | 1995-04-10 | Игорь Электринович Острейковский | Тонизирующее средство для улучшения самочувствия в условиях повышенной температуры окружающей среды |
EP0667162A1 (de) * | 1994-02-11 | 1995-08-16 | Rudolf Brunner | Pflanzliches Heilmittel und Verfahren zu dessen Herstellung |
ES2121348T3 (es) * | 1994-02-17 | 1998-11-16 | Merck Patent Gmbh | Composicion antiviral o antifungica y metodo. |
MX9700971A (es) * | 1994-08-08 | 1997-05-31 | Procter & Gamble | Composicion que contiene te y jugo de frutas con color estable. |
JPH0987188A (ja) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | 皮膚外用剤及び浴用剤 |
JP3213557B2 (ja) * | 1996-11-18 | 2001-10-02 | 三井農林株式会社 | 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤 |
-
1998
- 1998-06-23 US US09/102,355 patent/US6030622A/en not_active Expired - Fee Related
-
1999
- 1999-06-19 EA EA200000236A patent/EA003750B1/ru not_active IP Right Cessation
- 1999-06-19 ID IDW991710A patent/ID25661A/id unknown
- 1999-06-19 IL IL13344199A patent/IL133441A0/xx unknown
- 1999-06-19 KR KR1019997012550A patent/KR20010020586A/ko not_active Application Discontinuation
- 1999-06-19 PL PL99338263A patent/PL338263A1/xx unknown
- 1999-06-19 CA CA002294075A patent/CA2294075A1/en not_active Abandoned
- 1999-06-19 EP EP99930484A patent/EP1032409A4/en not_active Withdrawn
- 1999-06-19 NZ NZ501405A patent/NZ501405A/en unknown
- 1999-06-19 TR TR2000/00501T patent/TR200000501T1/xx unknown
- 1999-06-19 WO PCT/US1999/013949 patent/WO1999066941A1/en not_active Application Discontinuation
- 1999-06-19 SK SK1691-99A patent/SK169199A3/sk unknown
- 1999-06-19 CN CN99800880A patent/CN1272792A/zh active Pending
- 1999-06-19 JP JP2000555627A patent/JP2002518454A/ja active Pending
- 1999-06-19 EE EEP200000053A patent/EE200000053A/xx unknown
- 1999-06-19 BR BR9906480-4A patent/BR9906480A/pt not_active IP Right Cessation
- 1999-06-19 AU AU47018/99A patent/AU773546B2/en not_active Ceased
- 1999-11-22 NO NO995718A patent/NO995718L/no not_active Application Discontinuation
- 1999-12-08 BG BG103967A patent/BG63865B1/bg unknown
- 1999-12-15 ZA ZA9907713A patent/ZA997713B/xx unknown
- 1999-12-23 HR HR09/102,355A patent/HRP990407A2/hr not_active Application Discontinuation
-
2000
- 2000-01-07 AP APAP/P/2000/001727A patent/AP2000001727A0/en unknown
- 2000-02-04 OA OA1200000027A patent/OA11396A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1032409A1 (en) | 2000-09-06 |
BG63865B1 (bg) | 2003-04-30 |
SK169199A3 (en) | 2000-06-12 |
NZ501405A (en) | 2002-05-31 |
EA003750B1 (ru) | 2003-08-28 |
KR20010020586A (ko) | 2001-03-15 |
JP2002518454A (ja) | 2002-06-25 |
PL338263A1 (en) | 2000-10-09 |
AU4701899A (en) | 2000-01-10 |
ZA997713B (en) | 2000-08-01 |
BR9906480A (pt) | 2000-09-19 |
EP1032409A4 (en) | 2004-01-21 |
WO1999066941A1 (en) | 1999-12-29 |
AP2000001727A0 (en) | 2000-12-19 |
IL133441A0 (en) | 2001-04-30 |
BG103967A (en) | 2000-10-31 |
TR200000501T1 (tr) | 2000-11-21 |
OA11396A (en) | 2004-04-08 |
US6030622A (en) | 2000-02-29 |
HRP990407A2 (en) | 2000-04-30 |
EE200000053A (et) | 2000-10-16 |
NO995718D0 (no) | 1999-11-22 |
ID25661A (id) | 2000-10-19 |
EA200000236A1 (ru) | 2000-08-28 |
AU773546B2 (en) | 2004-05-27 |
CN1272792A (zh) | 2000-11-08 |
CA2294075A1 (en) | 1999-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995718L (no) | Urte-ekstraktsammensetning og metode med innum-"boosting"- evne | |
WO2002058684A3 (en) | Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders | |
IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
EP1352895A3 (en) | Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases | |
HK1026144A1 (en) | Aryl ureas for the treatment of inflammatory or immunomodulatory diseases. | |
DK0942740T3 (da) | Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme | |
NO993847D0 (no) | Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin | |
IL132293A0 (en) | Use of lactoferin in the treatment of allergen induced disorders | |
DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
WO2001001974A3 (en) | Naaladase inhibitors in anxiety and memory disorders | |
BG102623A (en) | New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms | |
SE9603725D0 (sv) | New teatment | |
TR199700801T1 (xx) | İnterleukin 12 kullanılarak angiogenesisin önlenmesi. | |
BG105275A (en) | Tan-1057 derivatives | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
GR3034155T3 (en) | Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer | |
DK0739354T3 (da) | Præparater og fremgangsmåder, hvor der anvendes ikke-bundet MPL-receptor til stimulering af blodpladeproduktion | |
HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use | |
MD1140B1 (en) | Remedy possessing a regenerative and cytoprotective activity | |
JO2143B1 (en) | Herbal Extract and How To Use It To Boost Immunity | |
UA40974A (uk) | Спосіб лікування міопії у дітей та підлітків | |
UA33478A (uk) | Спосіб лікування виразкової хвороби шлунка і дванадцятипалої кишки | |
PT758245E (pt) | Utilizacao da espiramicina nas doencas gastrointestinais devidas a h. pylori | |
GEU1999424Y (en) | Medicinal Ointment “Mdivnishvili-1” |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |